DUBLIN--(BUSINESS WIRE)--The "Topical Pain Relief Market Analysis by Formulation, by Type (Prescription Pain Reliefs, Over-The-Counter Pain Reliefs), by Distribution Channel, and by Region - Global Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.
The less adverse effects than those of traditional oral medications, rising demand among athletes for topical analgesics, increase in the number of elderly people, and the prevalence of arthritis are some of the primary market drivers. However, the unfavorable smells and adverse symptoms related to painkillers are expected to restrain the market growth.
Segmentation: Topical Pain Relief Market Analysis Report 2021-2029 Formulation (Revenue, USD Million)
- Spray
- Patch
- Gel
- Cream
- Others
Type (Revenue, USD Million)
- Prescription pain reliefs
- Over-the-counter (OTC) pain reliefs
Distribution Channel (Revenue, USD Million)
- Retail & grocery stores.
- Pharmacies & drug stores
- E-commerce
Therapeutic Class (Revenue, USD Million)
- Non-opioids
- Opioids
By Region (Revenue, USD Million)
North America
- U.S
- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Key Topics Covered:
1. Research Methodology
2. Introduction: Thyroid Cancer Diagnosis
3. Executive Summary
4. Market Dynamics
5. Market Environment Analysis
6. COVID-19 Impact Analysis: Thyroid Cancer Diagnosis Market
7. Market Analysis by Technique
8. Market Analysis by Type
9. Market Analysis by End-use
10. Regional Market Analysis
11. North America Thyroid Cancer Diagnosis Market
12. Europe Thyroid Cancer Diagnosis Market
13. Asia Pacific Thyroid Cancer Diagnosis Market
14. Latin America Thyroid Cancer Diagnosis Market
15. MEA Thyroid Cancer Diagnosis Market
16. Competitor Analysis
17. Company Profiles
18. Conclusion
19. Recommendations
Companies Mentioned
- AdvaCare Pharma (India)
- Exzell Pharma (Canada)
- GlaxoSmithKline Plc (UK)
- Johnson & Johnson (US)
- Novartis AG (Switzerland)
- Pfizer Inc (US)
- Reckitt Benckiser Group plc (UK)
- Sanofi (France)
- Sun Pharmaceutical Industries Ltd (India)
- Topical BioMedics (US),
For more information about this report visit https://www.researchandmarkets.com/r/hdhjlx
